nodes	percent_of_prediction	percent_of_DWPC	metapath
Roxithromycin—CYP2B6—Thiotepa—urinary bladder cancer	0.224	0.278	CbGbCtD
Roxithromycin—ABCB1—Mitomycin—urinary bladder cancer	0.152	0.188	CbGbCtD
Roxithromycin—CYP3A4—Thiotepa—urinary bladder cancer	0.0688	0.0854	CbGbCtD
Roxithromycin—CYP2B6—Cisplatin—urinary bladder cancer	0.0618	0.0767	CbGbCtD
Roxithromycin—ABCB1—Gemcitabine—urinary bladder cancer	0.0436	0.0541	CbGbCtD
Roxithromycin—CYP1A2—Fluorouracil—urinary bladder cancer	0.0427	0.053	CbGbCtD
Roxithromycin—CYP2B6—Doxorubicin—urinary bladder cancer	0.0414	0.0514	CbGbCtD
Roxithromycin—CYP1A2—Etoposide—urinary bladder cancer	0.0356	0.0442	CbGbCtD
Roxithromycin—ABCB1—Cisplatin—urinary bladder cancer	0.0317	0.0393	CbGbCtD
Roxithromycin—ABCB1—Etoposide—urinary bladder cancer	0.0312	0.0387	CbGbCtD
Roxithromycin—ABCB1—Doxorubicin—urinary bladder cancer	0.0212	0.0264	CbGbCtD
Roxithromycin—ABCB1—Methotrexate—urinary bladder cancer	0.0206	0.0255	CbGbCtD
Roxithromycin—CYP3A4—Etoposide—urinary bladder cancer	0.0187	0.0232	CbGbCtD
Roxithromycin—CYP3A4—Doxorubicin—urinary bladder cancer	0.0127	0.0158	CbGbCtD
Roxithromycin—Generalised oedema—Thiotepa—urinary bladder cancer	0.00291	0.0213	CcSEcCtD
Roxithromycin—Generalised oedema—Gemcitabine—urinary bladder cancer	0.00245	0.0179	CcSEcCtD
Roxithromycin—Thrombocytosis—Gemcitabine—urinary bladder cancer	0.00234	0.0171	CcSEcCtD
Roxithromycin—Generalised oedema—Cisplatin—urinary bladder cancer	0.00228	0.0167	CcSEcCtD
Roxithromycin—Flatulence—Valrubicin—urinary bladder cancer	0.00215	0.0157	CcSEcCtD
Roxithromycin—Ill-defined disorder—Valrubicin—urinary bladder cancer	0.00203	0.0148	CcSEcCtD
Roxithromycin—Malaise—Valrubicin—urinary bladder cancer	0.00197	0.0144	CcSEcCtD
Roxithromycin—Discomfort—Valrubicin—urinary bladder cancer	0.00184	0.0134	CcSEcCtD
Roxithromycin—Hearing impaired—Thiotepa—urinary bladder cancer	0.00182	0.0133	CcSEcCtD
Roxithromycin—Fluid retention—Thiotepa—urinary bladder cancer	0.00164	0.012	CcSEcCtD
Roxithromycin—Liver injury—Cisplatin—urinary bladder cancer	0.00161	0.0118	CcSEcCtD
Roxithromycin—Hearing impaired—Gemcitabine—urinary bladder cancer	0.00153	0.0112	CcSEcCtD
Roxithromycin—Feeling abnormal—Valrubicin—urinary bladder cancer	0.00147	0.0107	CcSEcCtD
Roxithromycin—Hearing impaired—Cisplatin—urinary bladder cancer	0.00143	0.0104	CcSEcCtD
Roxithromycin—Deafness—Thiotepa—urinary bladder cancer	0.00141	0.0103	CcSEcCtD
Roxithromycin—Ill-defined disorder—Mitomycin—urinary bladder cancer	0.0014	0.0102	CcSEcCtD
Roxithromycin—Fluid retention—Gemcitabine—urinary bladder cancer	0.00138	0.0101	CcSEcCtD
Roxithromycin—Hepatocellular injury—Cisplatin—urinary bladder cancer	0.00136	0.00993	CcSEcCtD
Roxithromycin—Malaise—Mitomycin—urinary bladder cancer	0.00136	0.00992	CcSEcCtD
Roxithromycin—Fluid retention—Cisplatin—urinary bladder cancer	0.00129	0.00942	CcSEcCtD
Roxithromycin—Discomfort—Mitomycin—urinary bladder cancer	0.00127	0.00926	CcSEcCtD
Roxithromycin—Pruritus—Valrubicin—urinary bladder cancer	0.00126	0.00922	CcSEcCtD
Roxithromycin—Diarrhoea—Valrubicin—urinary bladder cancer	0.00122	0.00892	CcSEcCtD
Roxithromycin—Candida infection—Etoposide—urinary bladder cancer	0.00119	0.00868	CcSEcCtD
Roxithromycin—Deafness—Gemcitabine—urinary bladder cancer	0.00118	0.00864	CcSEcCtD
Roxithromycin—Dizziness—Valrubicin—urinary bladder cancer	0.00118	0.00862	CcSEcCtD
Roxithromycin—Generalised oedema—Epirubicin—urinary bladder cancer	0.00117	0.00857	CcSEcCtD
Roxithromycin—Anorexia—Mitomycin—urinary bladder cancer	0.00117	0.00856	CcSEcCtD
Roxithromycin—Vomiting—Valrubicin—urinary bladder cancer	0.00113	0.00829	CcSEcCtD
Roxithromycin—Rash—Valrubicin—urinary bladder cancer	0.00112	0.00822	CcSEcCtD
Roxithromycin—Dermatitis—Valrubicin—urinary bladder cancer	0.00112	0.00821	CcSEcCtD
Roxithromycin—Thrombocytosis—Epirubicin—urinary bladder cancer	0.00112	0.0082	CcSEcCtD
Roxithromycin—Headache—Valrubicin—urinary bladder cancer	0.00112	0.00817	CcSEcCtD
Roxithromycin—Deafness—Cisplatin—urinary bladder cancer	0.0011	0.00806	CcSEcCtD
Roxithromycin—Generalised oedema—Doxorubicin—urinary bladder cancer	0.00108	0.00793	CcSEcCtD
Roxithromycin—Decreased appetite—Mitomycin—urinary bladder cancer	0.00107	0.00781	CcSEcCtD
Roxithromycin—Nausea—Valrubicin—urinary bladder cancer	0.00106	0.00774	CcSEcCtD
Roxithromycin—Thrombocytosis—Doxorubicin—urinary bladder cancer	0.00104	0.00759	CcSEcCtD
Roxithromycin—Feeling abnormal—Mitomycin—urinary bladder cancer	0.00101	0.0074	CcSEcCtD
Roxithromycin—Jaundice—Thiotepa—urinary bladder cancer	0.000944	0.0069	CcSEcCtD
Roxithromycin—Bronchospasm—Gemcitabine—urinary bladder cancer	0.000899	0.00657	CcSEcCtD
Roxithromycin—Eosinophilia—Fluorouracil—urinary bladder cancer	0.00089	0.0065	CcSEcCtD
Roxithromycin—Hallucination—Thiotepa—urinary bladder cancer	0.000865	0.00633	CcSEcCtD
Roxithromycin—Diarrhoea—Mitomycin—urinary bladder cancer	0.000841	0.00615	CcSEcCtD
Roxithromycin—Pancreatitis—Cisplatin—urinary bladder cancer	0.000835	0.00611	CcSEcCtD
Roxithromycin—Liver injury—Epirubicin—urinary bladder cancer	0.000829	0.00606	CcSEcCtD
Roxithromycin—Dizziness—Mitomycin—urinary bladder cancer	0.000813	0.00594	CcSEcCtD
Roxithromycin—Tinnitus—Thiotepa—urinary bladder cancer	0.000811	0.00593	CcSEcCtD
Roxithromycin—Stevens-Johnson syndrome—Gemcitabine—urinary bladder cancer	0.000808	0.00591	CcSEcCtD
Roxithromycin—Vomiting—Mitomycin—urinary bladder cancer	0.000781	0.00571	CcSEcCtD
Roxithromycin—Rash—Mitomycin—urinary bladder cancer	0.000775	0.00566	CcSEcCtD
Roxithromycin—Dermatitis—Mitomycin—urinary bladder cancer	0.000774	0.00566	CcSEcCtD
Roxithromycin—Headache—Mitomycin—urinary bladder cancer	0.00077	0.00563	CcSEcCtD
Roxithromycin—Bronchospasm—Etoposide—urinary bladder cancer	0.000768	0.00561	CcSEcCtD
Roxithromycin—Liver injury—Doxorubicin—urinary bladder cancer	0.000767	0.00561	CcSEcCtD
Roxithromycin—Nausea—Mitomycin—urinary bladder cancer	0.00073	0.00534	CcSEcCtD
Roxithromycin—Hepatocellular injury—Epirubicin—urinary bladder cancer	0.000697	0.0051	CcSEcCtD
Roxithromycin—Erythema multiforme—Gemcitabine—urinary bladder cancer	0.000692	0.00506	CcSEcCtD
Roxithromycin—Stevens-Johnson syndrome—Etoposide—urinary bladder cancer	0.00069	0.00504	CcSEcCtD
Roxithromycin—Jaundice—Etoposide—urinary bladder cancer	0.000678	0.00496	CcSEcCtD
Roxithromycin—Candida infection—Epirubicin—urinary bladder cancer	0.000666	0.00487	CcSEcCtD
Roxithromycin—Fluid retention—Epirubicin—urinary bladder cancer	0.000662	0.00484	CcSEcCtD
Roxithromycin—Hepatocellular injury—Doxorubicin—urinary bladder cancer	0.000645	0.00472	CcSEcCtD
Roxithromycin—Tinnitus—Cisplatin—urinary bladder cancer	0.000636	0.00465	CcSEcCtD
Roxithromycin—Candida infection—Doxorubicin—urinary bladder cancer	0.000616	0.0045	CcSEcCtD
Roxithromycin—Fluid retention—Doxorubicin—urinary bladder cancer	0.000613	0.00448	CcSEcCtD
Roxithromycin—Ill-defined disorder—Gemcitabine—urinary bladder cancer	0.000591	0.00432	CcSEcCtD
Roxithromycin—Erythema multiforme—Etoposide—urinary bladder cancer	0.000591	0.00432	CcSEcCtD
Roxithromycin—Anorexia—Thiotepa—urinary bladder cancer	0.000589	0.00431	CcSEcCtD
Roxithromycin—Flatulence—Cisplatin—urinary bladder cancer	0.000585	0.00428	CcSEcCtD
Roxithromycin—Malaise—Gemcitabine—urinary bladder cancer	0.000574	0.0042	CcSEcCtD
Roxithromycin—CYP1A2—Estrogen metabolism—NQO1—urinary bladder cancer	0.000573	0.00999	CbGpPWpGaD
Roxithromycin—Dermatitis exfoliative—Methotrexate—urinary bladder cancer	0.000573	0.00419	CcSEcCtD
Roxithromycin—Vascular purpura—Epirubicin—urinary bladder cancer	0.000566	0.00414	CcSEcCtD
Roxithromycin—Paraesthesia—Thiotepa—urinary bladder cancer	0.000555	0.00406	CcSEcCtD
Roxithromycin—Ill-defined disorder—Cisplatin—urinary bladder cancer	0.000551	0.00403	CcSEcCtD
Roxithromycin—Dyspepsia—Thiotepa—urinary bladder cancer	0.000544	0.00398	CcSEcCtD
Roxithromycin—Decreased appetite—Thiotepa—urinary bladder cancer	0.000537	0.00393	CcSEcCtD
Roxithromycin—Dermatitis exfoliative—Epirubicin—urinary bladder cancer	0.000536	0.00392	CcSEcCtD
Roxithromycin—Discomfort—Gemcitabine—urinary bladder cancer	0.000536	0.00392	CcSEcCtD
Roxithromycin—Malaise—Cisplatin—urinary bladder cancer	0.000535	0.00391	CcSEcCtD
Roxithromycin—Discomfort—Fluorouracil—urinary bladder cancer	0.000527	0.00385	CcSEcCtD
Roxithromycin—Purpura—Epirubicin—urinary bladder cancer	0.000525	0.00384	CcSEcCtD
Roxithromycin—Vascular purpura—Doxorubicin—urinary bladder cancer	0.000524	0.00383	CcSEcCtD
Roxithromycin—Anaphylactic shock—Gemcitabine—urinary bladder cancer	0.00052	0.0038	CcSEcCtD
Roxithromycin—ABCB1—Constitutive Androstane Receptor Pathway—SMC1A—urinary bladder cancer	0.000516	0.009	CbGpPWpGaD
Roxithromycin—Anaphylactic shock—Fluorouracil—urinary bladder cancer	0.000511	0.00374	CcSEcCtD
Roxithromycin—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP4B1—urinary bladder cancer	0.00051	0.0089	CbGpPWpGaD
Roxithromycin—Feeling abnormal—Thiotepa—urinary bladder cancer	0.000509	0.00372	CcSEcCtD
Roxithromycin—Ill-defined disorder—Etoposide—urinary bladder cancer	0.000505	0.00369	CcSEcCtD
Roxithromycin—CYP1A2—Oxidation by Cytochrome P450—CYP4B1—urinary bladder cancer	0.000504	0.00878	CbGpPWpGaD
Roxithromycin—Discomfort—Cisplatin—urinary bladder cancer	0.000499	0.00365	CcSEcCtD
Roxithromycin—Dermatitis exfoliative—Doxorubicin—urinary bladder cancer	0.000496	0.00363	CcSEcCtD
Roxithromycin—Anorexia—Gemcitabine—urinary bladder cancer	0.000495	0.00362	CcSEcCtD
Roxithromycin—Urticaria—Thiotepa—urinary bladder cancer	0.000491	0.00359	CcSEcCtD
Roxithromycin—Malaise—Etoposide—urinary bladder cancer	0.00049	0.00359	CcSEcCtD
Roxithromycin—Vertigo—Etoposide—urinary bladder cancer	0.000489	0.00357	CcSEcCtD
Roxithromycin—Anorexia—Fluorouracil—urinary bladder cancer	0.000487	0.00356	CcSEcCtD
Roxithromycin—Purpura—Doxorubicin—urinary bladder cancer	0.000486	0.00355	CcSEcCtD
Roxithromycin—Anaphylactic shock—Cisplatin—urinary bladder cancer	0.000485	0.00354	CcSEcCtD
Roxithromycin—CYP1A2—Phase II conjugation—GSTZ1—urinary bladder cancer	0.000481	0.00839	CbGpPWpGaD
Roxithromycin—CYP2B6—Biological oxidations—GSTZ1—urinary bladder cancer	0.000478	0.00833	CbGpPWpGaD
Roxithromycin—CYP2B6—Metapathway biotransformation—GSTZ1—urinary bladder cancer	0.000472	0.00822	CbGpPWpGaD
Roxithromycin—Asthma—Methotrexate—urinary bladder cancer	0.000468	0.00342	CcSEcCtD
Roxithromycin—Paraesthesia—Gemcitabine—urinary bladder cancer	0.000467	0.00341	CcSEcCtD
Roxithromycin—Eosinophilia—Methotrexate—urinary bladder cancer	0.000463	0.00338	CcSEcCtD
Roxithromycin—Abdominal pain upper—Epirubicin—urinary bladder cancer	0.000462	0.00338	CcSEcCtD
Roxithromycin—Anorexia—Cisplatin—urinary bladder cancer	0.000462	0.00338	CcSEcCtD
Roxithromycin—Paraesthesia—Fluorouracil—urinary bladder cancer	0.000459	0.00335	CcSEcCtD
Roxithromycin—Pancreatitis—Methotrexate—urinary bladder cancer	0.000458	0.00335	CcSEcCtD
Roxithromycin—Discomfort—Etoposide—urinary bladder cancer	0.000457	0.00334	CcSEcCtD
Roxithromycin—CYP1A2—Phase II conjugation—GSTO2—urinary bladder cancer	0.000456	0.00795	CbGpPWpGaD
Roxithromycin—CYP1A2—Phase II conjugation—NAT1—urinary bladder cancer	0.000456	0.00795	CbGpPWpGaD
Roxithromycin—Hypersensitivity—Thiotepa—urinary bladder cancer	0.000455	0.00333	CcSEcCtD
Roxithromycin—CYP2B6—Biological oxidations—GSTO2—urinary bladder cancer	0.000453	0.0079	CbGpPWpGaD
Roxithromycin—CYP2B6—Biological oxidations—NAT1—urinary bladder cancer	0.000453	0.0079	CbGpPWpGaD
Roxithromycin—Decreased appetite—Gemcitabine—urinary bladder cancer	0.000452	0.0033	CcSEcCtD
Roxithromycin—Dyspepsia—Fluorouracil—urinary bladder cancer	0.00045	0.00329	CcSEcCtD
Roxithromycin—CYP1A2—Estrogen Receptor Pathway—ESR1—urinary bladder cancer	0.000448	0.00781	CbGpPWpGaD
Roxithromycin—CYP2B6—Metapathway biotransformation—GSTO2—urinary bladder cancer	0.000447	0.00779	CbGpPWpGaD
Roxithromycin—Decreased appetite—Fluorouracil—urinary bladder cancer	0.000444	0.00325	CcSEcCtD
Roxithromycin—Anaphylactic shock—Etoposide—urinary bladder cancer	0.000444	0.00324	CcSEcCtD
Roxithromycin—CYP3A4—Estrogen metabolism—NQO1—urinary bladder cancer	0.000442	0.00771	CbGpPWpGaD
Roxithromycin—CYP1A2—Estrogen metabolism—GSTM1—urinary bladder cancer	0.000439	0.00766	CbGpPWpGaD
Roxithromycin—Asthma—Epirubicin—urinary bladder cancer	0.000438	0.0032	CcSEcCtD
Roxithromycin—Pruritus—Thiotepa—urinary bladder cancer	0.000437	0.0032	CcSEcCtD
Roxithromycin—Paraesthesia—Cisplatin—urinary bladder cancer	0.000435	0.00318	CcSEcCtD
Roxithromycin—Eosinophilia—Epirubicin—urinary bladder cancer	0.000433	0.00317	CcSEcCtD
Roxithromycin—Pancreatitis—Epirubicin—urinary bladder cancer	0.000429	0.00314	CcSEcCtD
Roxithromycin—Feeling abnormal—Gemcitabine—urinary bladder cancer	0.000428	0.00313	CcSEcCtD
Roxithromycin—Abdominal pain upper—Doxorubicin—urinary bladder cancer	0.000428	0.00313	CcSEcCtD
Roxithromycin—Anorexia—Etoposide—urinary bladder cancer	0.000423	0.00309	CcSEcCtD
Roxithromycin—Diarrhoea—Thiotepa—urinary bladder cancer	0.000423	0.00309	CcSEcCtD
Roxithromycin—Decreased appetite—Cisplatin—urinary bladder cancer	0.000421	0.00308	CcSEcCtD
Roxithromycin—Feeling abnormal—Fluorouracil—urinary bladder cancer	0.000421	0.00308	CcSEcCtD
Roxithromycin—CYP1A2—Phase II conjugation—UGT2B7—urinary bladder cancer	0.000417	0.00727	CbGpPWpGaD
Roxithromycin—CYP2B6—Biological oxidations—UGT2B7—urinary bladder cancer	0.000415	0.00723	CbGpPWpGaD
Roxithromycin—CYP1A2—Phase 1 - Functionalization of compounds—CYP4B1—urinary bladder cancer	0.000414	0.00721	CbGpPWpGaD
Roxithromycin—Stevens-Johnson syndrome—Methotrexate—urinary bladder cancer	0.000413	0.00302	CcSEcCtD
Roxithromycin—CYP2B6—Metapathway biotransformation—UGT2B7—urinary bladder cancer	0.000409	0.00713	CbGpPWpGaD
Roxithromycin—Dizziness—Thiotepa—urinary bladder cancer	0.000409	0.00299	CcSEcCtD
Roxithromycin—Urticaria—Fluorouracil—urinary bladder cancer	0.000406	0.00297	CcSEcCtD
Roxithromycin—Asthma—Doxorubicin—urinary bladder cancer	0.000405	0.00296	CcSEcCtD
Roxithromycin—Eosinophilia—Doxorubicin—urinary bladder cancer	0.000401	0.00293	CcSEcCtD
Roxithromycin—Feeling abnormal—Cisplatin—urinary bladder cancer	0.000399	0.00292	CcSEcCtD
Roxithromycin—Paraesthesia—Etoposide—urinary bladder cancer	0.000399	0.00291	CcSEcCtD
Roxithromycin—Pancreatitis—Doxorubicin—urinary bladder cancer	0.000397	0.0029	CcSEcCtD
Roxithromycin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP4B1—urinary bladder cancer	0.000394	0.00687	CbGpPWpGaD
Roxithromycin—Vomiting—Thiotepa—urinary bladder cancer	0.000393	0.00287	CcSEcCtD
Roxithromycin—Rash—Thiotepa—urinary bladder cancer	0.00039	0.00285	CcSEcCtD
Roxithromycin—Dermatitis—Thiotepa—urinary bladder cancer	0.000389	0.00285	CcSEcCtD
Roxithromycin—CYP3A4—Oxidation by Cytochrome P450—CYP4B1—urinary bladder cancer	0.000389	0.00678	CbGpPWpGaD
Roxithromycin—Headache—Thiotepa—urinary bladder cancer	0.000387	0.00283	CcSEcCtD
Roxithromycin—Stevens-Johnson syndrome—Epirubicin—urinary bladder cancer	0.000387	0.00283	CcSEcCtD
Roxithromycin—Decreased appetite—Etoposide—urinary bladder cancer	0.000386	0.00282	CcSEcCtD
Roxithromycin—Jaundice—Epirubicin—urinary bladder cancer	0.00038	0.00278	CcSEcCtD
Roxithromycin—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.000377	0.00275	CcSEcCtD
Roxithromycin—CYP2B6—Biological oxidations—CYP4B1—urinary bladder cancer	0.000373	0.00651	CbGpPWpGaD
Roxithromycin—CYP2B6—Metapathway biotransformation—CYP4B1—urinary bladder cancer	0.000368	0.00642	CbGpPWpGaD
Roxithromycin—Pruritus—Gemcitabine—urinary bladder cancer	0.000368	0.00269	CcSEcCtD
Roxithromycin—Nausea—Thiotepa—urinary bladder cancer	0.000367	0.00268	CcSEcCtD
Roxithromycin—Feeling abnormal—Etoposide—urinary bladder cancer	0.000366	0.00267	CcSEcCtD
Roxithromycin—Pruritus—Fluorouracil—urinary bladder cancer	0.000362	0.00264	CcSEcCtD
Roxithromycin—Stevens-Johnson syndrome—Doxorubicin—urinary bladder cancer	0.000358	0.00262	CcSEcCtD
Roxithromycin—Hypersensitivity—Cisplatin—urinary bladder cancer	0.000357	0.00261	CcSEcCtD
Roxithromycin—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000356	0.0026	CcSEcCtD
Roxithromycin—Erythema multiforme—Methotrexate—urinary bladder cancer	0.000354	0.00259	CcSEcCtD
Roxithromycin—Urticaria—Etoposide—urinary bladder cancer	0.000353	0.00258	CcSEcCtD
Roxithromycin—Jaundice—Doxorubicin—urinary bladder cancer	0.000352	0.00257	CcSEcCtD
Roxithromycin—Diarrhoea—Fluorouracil—urinary bladder cancer	0.00035	0.00256	CcSEcCtD
Roxithromycin—Tinnitus—Methotrexate—urinary bladder cancer	0.000349	0.00255	CcSEcCtD
Roxithromycin—CYP3A4—Estrogen metabolism—GSTM1—urinary bladder cancer	0.000339	0.00591	CbGpPWpGaD
Roxithromycin—Dizziness—Fluorouracil—urinary bladder cancer	0.000338	0.00247	CcSEcCtD
Roxithromycin—CYP1A2—Aryl Hydrocarbon Receptor—HPGDS—urinary bladder cancer	0.000336	0.00585	CbGpPWpGaD
Roxithromycin—Diarrhoea—Cisplatin—urinary bladder cancer	0.000332	0.00242	CcSEcCtD
Roxithromycin—Erythema multiforme—Epirubicin—urinary bladder cancer	0.000331	0.00242	CcSEcCtD
Roxithromycin—Vomiting—Gemcitabine—urinary bladder cancer	0.000331	0.00242	CcSEcCtD
Roxithromycin—Rash—Gemcitabine—urinary bladder cancer	0.000328	0.0024	CcSEcCtD
Roxithromycin—Dermatitis—Gemcitabine—urinary bladder cancer	0.000327	0.00239	CcSEcCtD
Roxithromycin—Hypersensitivity—Etoposide—urinary bladder cancer	0.000327	0.00239	CcSEcCtD
Roxithromycin—Tinnitus—Epirubicin—urinary bladder cancer	0.000327	0.00239	CcSEcCtD
Roxithromycin—Headache—Gemcitabine—urinary bladder cancer	0.000326	0.00238	CcSEcCtD
Roxithromycin—Vomiting—Fluorouracil—urinary bladder cancer	0.000325	0.00238	CcSEcCtD
Roxithromycin—Rash—Fluorouracil—urinary bladder cancer	0.000322	0.00236	CcSEcCtD
Roxithromycin—Dermatitis—Fluorouracil—urinary bladder cancer	0.000322	0.00235	CcSEcCtD
Roxithromycin—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—urinary bladder cancer	0.000322	0.00561	CbGpPWpGaD
Roxithromycin—Headache—Fluorouracil—urinary bladder cancer	0.00032	0.00234	CcSEcCtD
Roxithromycin—CYP3A4—Phase 1 - Functionalization of compounds—CYP4B1—urinary bladder cancer	0.000319	0.00557	CbGpPWpGaD
Roxithromycin—CYP3A4—Constitutive Androstane Receptor Pathway—SMC1A—urinary bladder cancer	0.000318	0.00554	CbGpPWpGaD
Roxithromycin—CYP1A2—Arachidonic acid metabolism—HPGDS—urinary bladder cancer	0.000314	0.00548	CbGpPWpGaD
Roxithromycin—Pruritus—Etoposide—urinary bladder cancer	0.000314	0.0023	CcSEcCtD
Roxithromycin—Nausea—Gemcitabine—urinary bladder cancer	0.000309	0.00226	CcSEcCtD
Roxithromycin—Vomiting—Cisplatin—urinary bladder cancer	0.000308	0.00225	CcSEcCtD
Roxithromycin—Erythema multiforme—Doxorubicin—urinary bladder cancer	0.000306	0.00224	CcSEcCtD
Roxithromycin—Rash—Cisplatin—urinary bladder cancer	0.000305	0.00223	CcSEcCtD
Roxithromycin—Dermatitis—Cisplatin—urinary bladder cancer	0.000305	0.00223	CcSEcCtD
Roxithromycin—Diarrhoea—Etoposide—urinary bladder cancer	0.000304	0.00222	CcSEcCtD
Roxithromycin—Nausea—Fluorouracil—urinary bladder cancer	0.000304	0.00222	CcSEcCtD
Roxithromycin—Ill-defined disorder—Methotrexate—urinary bladder cancer	0.000302	0.00221	CcSEcCtD
Roxithromycin—Tinnitus—Doxorubicin—urinary bladder cancer	0.000302	0.00221	CcSEcCtD
Roxithromycin—Flatulence—Epirubicin—urinary bladder cancer	0.0003	0.0022	CcSEcCtD
Roxithromycin—Malaise—Methotrexate—urinary bladder cancer	0.000294	0.00215	CcSEcCtD
Roxithromycin—Dizziness—Etoposide—urinary bladder cancer	0.000294	0.00215	CcSEcCtD
Roxithromycin—Vertigo—Methotrexate—urinary bladder cancer	0.000293	0.00214	CcSEcCtD
Roxithromycin—Nausea—Cisplatin—urinary bladder cancer	0.000288	0.0021	CcSEcCtD
Roxithromycin—ABCB1—HIF-1-alpha transcription factor network—TFRC—urinary bladder cancer	0.000286	0.00499	CbGpPWpGaD
Roxithromycin—Ill-defined disorder—Epirubicin—urinary bladder cancer	0.000283	0.00207	CcSEcCtD
Roxithromycin—Vomiting—Etoposide—urinary bladder cancer	0.000282	0.00206	CcSEcCtD
Roxithromycin—CYP1A2—Biological oxidations—GSTZ1—urinary bladder cancer	0.000282	0.00491	CbGpPWpGaD
Roxithromycin—Rash—Etoposide—urinary bladder cancer	0.00028	0.00205	CcSEcCtD
Roxithromycin—Dermatitis—Etoposide—urinary bladder cancer	0.00028	0.00204	CcSEcCtD
Roxithromycin—Headache—Etoposide—urinary bladder cancer	0.000278	0.00203	CcSEcCtD
Roxithromycin—Flatulence—Doxorubicin—urinary bladder cancer	0.000278	0.00203	CcSEcCtD
Roxithromycin—CYP1A2—Metapathway biotransformation—GSTZ1—urinary bladder cancer	0.000278	0.00484	CbGpPWpGaD
Roxithromycin—Malaise—Epirubicin—urinary bladder cancer	0.000275	0.00201	CcSEcCtD
Roxithromycin—Discomfort—Methotrexate—urinary bladder cancer	0.000274	0.002	CcSEcCtD
Roxithromycin—Vertigo—Epirubicin—urinary bladder cancer	0.000274	0.002	CcSEcCtD
Roxithromycin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—NQO1—urinary bladder cancer	0.000271	0.00472	CbGpPWpGaD
Roxithromycin—CYP1A2—Aryl Hydrocarbon Receptor—NQO1—urinary bladder cancer	0.000271	0.00472	CbGpPWpGaD
Roxithromycin—CYP1A2—Biological oxidations—GSTO2—urinary bladder cancer	0.000267	0.00465	CbGpPWpGaD
Roxithromycin—CYP1A2—Biological oxidations—NAT1—urinary bladder cancer	0.000267	0.00465	CbGpPWpGaD
Roxithromycin—Anaphylactic shock—Methotrexate—urinary bladder cancer	0.000266	0.00194	CcSEcCtD
Roxithromycin—Nausea—Etoposide—urinary bladder cancer	0.000264	0.00193	CcSEcCtD
Roxithromycin—CYP1A2—Metapathway biotransformation—GSTO2—urinary bladder cancer	0.000263	0.00459	CbGpPWpGaD
Roxithromycin—Ill-defined disorder—Doxorubicin—urinary bladder cancer	0.000262	0.00191	CcSEcCtD
Roxithromycin—Discomfort—Epirubicin—urinary bladder cancer	0.000256	0.00187	CcSEcCtD
Roxithromycin—Malaise—Doxorubicin—urinary bladder cancer	0.000254	0.00186	CcSEcCtD
Roxithromycin—Vertigo—Doxorubicin—urinary bladder cancer	0.000253	0.00185	CcSEcCtD
Roxithromycin—Anorexia—Methotrexate—urinary bladder cancer	0.000253	0.00185	CcSEcCtD
Roxithromycin—CYP1A2—Phase II conjugation—NAT2—urinary bladder cancer	0.00025	0.00436	CbGpPWpGaD
Roxithromycin—Anaphylactic shock—Epirubicin—urinary bladder cancer	0.000249	0.00182	CcSEcCtD
Roxithromycin—CYP2B6—Biological oxidations—NAT2—urinary bladder cancer	0.000248	0.00433	CbGpPWpGaD
Roxithromycin—CYP2B6—Metapathway biotransformation—NAT2—urinary bladder cancer	0.000245	0.00427	CbGpPWpGaD
Roxithromycin—CYP1A2—Biological oxidations—UGT2B7—urinary bladder cancer	0.000244	0.00425	CbGpPWpGaD
Roxithromycin—CYP1A2—Metapathway biotransformation—UGT2B7—urinary bladder cancer	0.000241	0.0042	CbGpPWpGaD
Roxithromycin—Paraesthesia—Methotrexate—urinary bladder cancer	0.000239	0.00175	CcSEcCtD
Roxithromycin—Discomfort—Doxorubicin—urinary bladder cancer	0.000237	0.00173	CcSEcCtD
Roxithromycin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—urinary bladder cancer	0.000237	0.00413	CbGpPWpGaD
Roxithromycin—Anorexia—Epirubicin—urinary bladder cancer	0.000237	0.00173	CcSEcCtD
Roxithromycin—Dyspepsia—Methotrexate—urinary bladder cancer	0.000234	0.00171	CcSEcCtD
Roxithromycin—Decreased appetite—Methotrexate—urinary bladder cancer	0.000231	0.00169	CcSEcCtD
Roxithromycin—Anaphylactic shock—Doxorubicin—urinary bladder cancer	0.00023	0.00168	CcSEcCtD
Roxithromycin—Paraesthesia—Epirubicin—urinary bladder cancer	0.000223	0.00163	CcSEcCtD
Roxithromycin—CYP1A2—Biological oxidations—CYP4B1—urinary bladder cancer	0.00022	0.00383	CbGpPWpGaD
Roxithromycin—Anorexia—Doxorubicin—urinary bladder cancer	0.000219	0.0016	CcSEcCtD
Roxithromycin—Feeling abnormal—Methotrexate—urinary bladder cancer	0.000219	0.0016	CcSEcCtD
Roxithromycin—Dyspepsia—Epirubicin—urinary bladder cancer	0.000219	0.0016	CcSEcCtD
Roxithromycin—CYP3A4—Biological oxidations—GSTZ1—urinary bladder cancer	0.000217	0.00379	CbGpPWpGaD
Roxithromycin—CYP1A2—Metapathway biotransformation—CYP4B1—urinary bladder cancer	0.000217	0.00378	CbGpPWpGaD
Roxithromycin—Decreased appetite—Epirubicin—urinary bladder cancer	0.000216	0.00158	CcSEcCtD
Roxithromycin—CYP3A4—Metapathway biotransformation—GSTZ1—urinary bladder cancer	0.000214	0.00374	CbGpPWpGaD
Roxithromycin—Urticaria—Methotrexate—urinary bladder cancer	0.000211	0.00154	CcSEcCtD
Roxithromycin—Paraesthesia—Doxorubicin—urinary bladder cancer	0.000207	0.00151	CcSEcCtD
Roxithromycin—CYP3A4—Biological oxidations—GSTO2—urinary bladder cancer	0.000206	0.00359	CbGpPWpGaD
Roxithromycin—CYP3A4—Biological oxidations—NAT1—urinary bladder cancer	0.000206	0.00359	CbGpPWpGaD
Roxithromycin—Feeling abnormal—Epirubicin—urinary bladder cancer	0.000205	0.0015	CcSEcCtD
Roxithromycin—CYP3A4—Metapathway biotransformation—GSTO2—urinary bladder cancer	0.000203	0.00354	CbGpPWpGaD
Roxithromycin—Dyspepsia—Doxorubicin—urinary bladder cancer	0.000203	0.00148	CcSEcCtD
Roxithromycin—Decreased appetite—Doxorubicin—urinary bladder cancer	0.0002	0.00146	CcSEcCtD
Roxithromycin—CYP1A2—Phase II conjugation—HPGDS—urinary bladder cancer	0.0002	0.00348	CbGpPWpGaD
Roxithromycin—CYP2B6—Biological oxidations—HPGDS—urinary bladder cancer	0.000199	0.00346	CbGpPWpGaD
Roxithromycin—Urticaria—Epirubicin—urinary bladder cancer	0.000198	0.00144	CcSEcCtD
Roxithromycin—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000196	0.00143	CcSEcCtD
Roxithromycin—CYP1A2—Phase II conjugation—GSTT1—urinary bladder cancer	0.000194	0.00338	CbGpPWpGaD
Roxithromycin—CYP2B6—Biological oxidations—GSTT1—urinary bladder cancer	0.000193	0.00336	CbGpPWpGaD
Roxithromycin—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.00019	0.00139	CcSEcCtD
Roxithromycin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—urinary bladder cancer	0.000189	0.0033	CbGpPWpGaD
Roxithromycin—CYP3A4—Biological oxidations—UGT2B7—urinary bladder cancer	0.000188	0.00328	CbGpPWpGaD
Roxithromycin—Pruritus—Methotrexate—urinary bladder cancer	0.000188	0.00138	CcSEcCtD
Roxithromycin—CYP1A2—Arachidonic acid metabolism—GPX1—urinary bladder cancer	0.000186	0.00324	CbGpPWpGaD
Roxithromycin—CYP3A4—Metapathway biotransformation—UGT2B7—urinary bladder cancer	0.000186	0.00324	CbGpPWpGaD
Roxithromycin—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000183	0.00134	CcSEcCtD
Roxithromycin—Urticaria—Doxorubicin—urinary bladder cancer	0.000183	0.00134	CcSEcCtD
Roxithromycin—Diarrhoea—Methotrexate—urinary bladder cancer	0.000182	0.00133	CcSEcCtD
Roxithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—LIG1—urinary bladder cancer	0.000177	0.00308	CbGpPWpGaD
Roxithromycin—Pruritus—Epirubicin—urinary bladder cancer	0.000176	0.00129	CcSEcCtD
Roxithromycin—Dizziness—Methotrexate—urinary bladder cancer	0.000176	0.00129	CcSEcCtD
Roxithromycin—ABCB1—HIF-1-alpha transcription factor network—TERT—urinary bladder cancer	0.000172	0.00299	CbGpPWpGaD
Roxithromycin—Diarrhoea—Epirubicin—urinary bladder cancer	0.00017	0.00124	CcSEcCtD
Roxithromycin—CYP3A4—Biological oxidations—CYP4B1—urinary bladder cancer	0.00017	0.00296	CbGpPWpGaD
Roxithromycin—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.00017	0.00124	CcSEcCtD
Roxithromycin—Vomiting—Methotrexate—urinary bladder cancer	0.000169	0.00124	CcSEcCtD
Roxithromycin—Rash—Methotrexate—urinary bladder cancer	0.000168	0.00123	CcSEcCtD
Roxithromycin—Dermatitis—Methotrexate—urinary bladder cancer	0.000167	0.00122	CcSEcCtD
Roxithromycin—CYP3A4—Metapathway biotransformation—CYP4B1—urinary bladder cancer	0.000167	0.00292	CbGpPWpGaD
Roxithromycin—Headache—Methotrexate—urinary bladder cancer	0.000167	0.00122	CcSEcCtD
Roxithromycin—Dizziness—Epirubicin—urinary bladder cancer	0.000165	0.0012	CcSEcCtD
Roxithromycin—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—urinary bladder cancer	0.000163	0.00284	CbGpPWpGaD
Roxithromycin—Pruritus—Doxorubicin—urinary bladder cancer	0.000163	0.00119	CcSEcCtD
Roxithromycin—Vomiting—Epirubicin—urinary bladder cancer	0.000158	0.00116	CcSEcCtD
Roxithromycin—Nausea—Methotrexate—urinary bladder cancer	0.000158	0.00115	CcSEcCtD
Roxithromycin—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000158	0.00115	CcSEcCtD
Roxithromycin—Rash—Epirubicin—urinary bladder cancer	0.000157	0.00115	CcSEcCtD
Roxithromycin—Dermatitis—Epirubicin—urinary bladder cancer	0.000157	0.00115	CcSEcCtD
Roxithromycin—Headache—Epirubicin—urinary bladder cancer	0.000156	0.00114	CcSEcCtD
Roxithromycin—Dizziness—Doxorubicin—urinary bladder cancer	0.000152	0.00111	CcSEcCtD
Roxithromycin—ABCB1—Allograft Rejection—FAS—urinary bladder cancer	0.000151	0.00263	CbGpPWpGaD
Roxithromycin—Nausea—Epirubicin—urinary bladder cancer	0.000148	0.00108	CcSEcCtD
Roxithromycin—Vomiting—Doxorubicin—urinary bladder cancer	0.000146	0.00107	CcSEcCtD
Roxithromycin—CYP1A2—Biological oxidations—NAT2—urinary bladder cancer	0.000146	0.00255	CbGpPWpGaD
Roxithromycin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—urinary bladder cancer	0.000146	0.00255	CbGpPWpGaD
Roxithromycin—Rash—Doxorubicin—urinary bladder cancer	0.000145	0.00106	CcSEcCtD
Roxithromycin—Dermatitis—Doxorubicin—urinary bladder cancer	0.000145	0.00106	CcSEcCtD
Roxithromycin—CYP1A2—Metapathway biotransformation—NAT2—urinary bladder cancer	0.000144	0.00251	CbGpPWpGaD
Roxithromycin—Headache—Doxorubicin—urinary bladder cancer	0.000144	0.00105	CcSEcCtD
Roxithromycin—CYP1A2—Aryl Hydrocarbon Receptor—RB1—urinary bladder cancer	0.000142	0.00248	CbGpPWpGaD
Roxithromycin—Nausea—Doxorubicin—urinary bladder cancer	0.000137	0.001	CcSEcCtD
Roxithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—HPGDS—urinary bladder cancer	0.000135	0.00235	CbGpPWpGaD
Roxithromycin—CYP1A2—Phase II conjugation—GSTP1—urinary bladder cancer	0.000134	0.00234	CbGpPWpGaD
Roxithromycin—ABCB1—HIF-1-alpha transcription factor network—CREBBP—urinary bladder cancer	0.000134	0.00234	CbGpPWpGaD
Roxithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—IGFBP3—urinary bladder cancer	0.000134	0.00233	CbGpPWpGaD
Roxithromycin—CYP2B6—Biological oxidations—GSTP1—urinary bladder cancer	0.000133	0.00233	CbGpPWpGaD
Roxithromycin—CYP2B6—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.000132	0.00229	CbGpPWpGaD
Roxithromycin—CYP1A2—Phase II conjugation—GSTM1—urinary bladder cancer	0.000123	0.00215	CbGpPWpGaD
Roxithromycin—CYP2B6—Biological oxidations—GSTM1—urinary bladder cancer	0.000123	0.00214	CbGpPWpGaD
Roxithromycin—ABCB1—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	0.000122	0.00213	CbGpPWpGaD
Roxithromycin—CYP2B6—Metapathway biotransformation—GSTM1—urinary bladder cancer	0.000121	0.00211	CbGpPWpGaD
Roxithromycin—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—urinary bladder cancer	0.000117	0.00204	CbGpPWpGaD
Roxithromycin—CYP1A2—Biological oxidations—HPGDS—urinary bladder cancer	0.000117	0.00204	CbGpPWpGaD
Roxithromycin—CYP1A2—Biological oxidations—GSTT1—urinary bladder cancer	0.000113	0.00198	CbGpPWpGaD
Roxithromycin—CYP3A4—Biological oxidations—NAT2—urinary bladder cancer	0.000113	0.00197	CbGpPWpGaD
Roxithromycin—CYP3A4—Metapathway biotransformation—NAT2—urinary bladder cancer	0.000111	0.00194	CbGpPWpGaD
Roxithromycin—CYP1A2—Arachidonic acid metabolism—PTGS2—urinary bladder cancer	0.000109	0.00191	CbGpPWpGaD
Roxithromycin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—urinary bladder cancer	0.000108	0.00189	CbGpPWpGaD
Roxithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—urinary bladder cancer	0.000108	0.00188	CbGpPWpGaD
Roxithromycin—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—urinary bladder cancer	0.000102	0.00178	CbGpPWpGaD
Roxithromycin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—urinary bladder cancer	0.000101	0.00176	CbGpPWpGaD
Roxithromycin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—urinary bladder cancer	9.73e-05	0.0017	CbGpPWpGaD
Roxithromycin—CYP1A2—Aryl Hydrocarbon Receptor—EP300—urinary bladder cancer	9.73e-05	0.0017	CbGpPWpGaD
Roxithromycin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—SRC—urinary bladder cancer	9.46e-05	0.00165	CbGpPWpGaD
Roxithromycin—CYP1A2—Aryl Hydrocarbon Receptor—SRC—urinary bladder cancer	9.46e-05	0.00165	CbGpPWpGaD
Roxithromycin—ABCB1—Allograft Rejection—CXCL8—urinary bladder cancer	9.22e-05	0.00161	CbGpPWpGaD
Roxithromycin—ABCB1—HIF-1-alpha transcription factor network—EP300—urinary bladder cancer	9.13e-05	0.00159	CbGpPWpGaD
Roxithromycin—CYP3A4—Biological oxidations—HPGDS—urinary bladder cancer	9.02e-05	0.00157	CbGpPWpGaD
Roxithromycin—ABCB1—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	8.83e-05	0.00154	CbGpPWpGaD
Roxithromycin—ABCB1—Allograft Rejection—IL2—urinary bladder cancer	8.81e-05	0.00154	CbGpPWpGaD
Roxithromycin—CYP3A4—Biological oxidations—GSTT1—urinary bladder cancer	8.75e-05	0.00153	CbGpPWpGaD
Roxithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—CCNE1—urinary bladder cancer	8.57e-05	0.00149	CbGpPWpGaD
Roxithromycin—CYP1A2—Aryl Hydrocarbon Receptor—MYC—urinary bladder cancer	8.48e-05	0.00148	CbGpPWpGaD
Roxithromycin—CYP1A2—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	8.44e-05	0.00147	CbGpPWpGaD
Roxithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—urinary bladder cancer	8.42e-05	0.00147	CbGpPWpGaD
Roxithromycin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—urinary bladder cancer	8.29e-05	0.00145	CbGpPWpGaD
Roxithromycin—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—urinary bladder cancer	8.29e-05	0.00145	CbGpPWpGaD
Roxithromycin—CYP2B6—Metabolism—GSTZ1—urinary bladder cancer	8.18e-05	0.00143	CbGpPWpGaD
Roxithromycin—CYP1A2—Aryl Hydrocarbon Receptor—TNF—urinary bladder cancer	7.9e-05	0.00138	CbGpPWpGaD
Roxithromycin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—urinary bladder cancer	7.9e-05	0.00138	CbGpPWpGaD
Roxithromycin—CYP1A2—Biological oxidations—GSTP1—urinary bladder cancer	7.86e-05	0.00137	CbGpPWpGaD
Roxithromycin—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—urinary bladder cancer	7.83e-05	0.00137	CbGpPWpGaD
Roxithromycin—CYP2B6—Metabolism—GSTO2—urinary bladder cancer	7.75e-05	0.00135	CbGpPWpGaD
Roxithromycin—CYP2B6—Metabolism—NAT1—urinary bladder cancer	7.75e-05	0.00135	CbGpPWpGaD
Roxithromycin—CYP1A2—Metapathway biotransformation—GSTP1—urinary bladder cancer	7.75e-05	0.00135	CbGpPWpGaD
Roxithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—urinary bladder cancer	7.46e-05	0.0013	CbGpPWpGaD
Roxithromycin—CYP1A2—Biological oxidations—GSTM1—urinary bladder cancer	7.22e-05	0.00126	CbGpPWpGaD
Roxithromycin—ABCB1—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	7.19e-05	0.00125	CbGpPWpGaD
Roxithromycin—CYP1A2—Metapathway biotransformation—GSTM1—urinary bladder cancer	7.12e-05	0.00124	CbGpPWpGaD
Roxithromycin—CYP2B6—Metabolism—UGT2B7—urinary bladder cancer	7.09e-05	0.00124	CbGpPWpGaD
Roxithromycin—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—urinary bladder cancer	6.66e-05	0.00116	CbGpPWpGaD
Roxithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—ATM—urinary bladder cancer	6.59e-05	0.00115	CbGpPWpGaD
Roxithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—urinary bladder cancer	6.56e-05	0.00114	CbGpPWpGaD
Roxithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—urinary bladder cancer	6.54e-05	0.00114	CbGpPWpGaD
Roxithromycin—ABCB1—Allograft Rejection—TNF—urinary bladder cancer	6.42e-05	0.00112	CbGpPWpGaD
Roxithromycin—CYP2B6—Metabolism—CYP4B1—urinary bladder cancer	6.38e-05	0.00111	CbGpPWpGaD
Roxithromycin—CYP3A4—Biological oxidations—GSTP1—urinary bladder cancer	6.07e-05	0.00106	CbGpPWpGaD
Roxithromycin—ABCB1—Metabolism—GSTZ1—urinary bladder cancer	6.03e-05	0.00105	CbGpPWpGaD
Roxithromycin—CYP2B6—Metabolism—SLC19A1—urinary bladder cancer	6.03e-05	0.00105	CbGpPWpGaD
Roxithromycin—CYP3A4—Metapathway biotransformation—GSTP1—urinary bladder cancer	5.98e-05	0.00104	CbGpPWpGaD
Roxithromycin—CYP2B6—Metabolism—PRSS3—urinary bladder cancer	5.87e-05	0.00102	CbGpPWpGaD
Roxithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—urinary bladder cancer	5.73e-05	0.000998	CbGpPWpGaD
Roxithromycin—ABCB1—Metabolism—GSTO2—urinary bladder cancer	5.72e-05	0.000997	CbGpPWpGaD
Roxithromycin—ABCB1—Metabolism—NAT1—urinary bladder cancer	5.72e-05	0.000997	CbGpPWpGaD
Roxithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—urinary bladder cancer	5.66e-05	0.000986	CbGpPWpGaD
Roxithromycin—CYP3A4—Biological oxidations—GSTM1—urinary bladder cancer	5.57e-05	0.000972	CbGpPWpGaD
Roxithromycin—CYP3A4—Metapathway biotransformation—GSTM1—urinary bladder cancer	5.5e-05	0.000958	CbGpPWpGaD
Roxithromycin—ABCB1—Metabolism—UGT2B7—urinary bladder cancer	5.23e-05	0.000912	CbGpPWpGaD
Roxithromycin—ABCB1—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	4.86e-05	0.000847	CbGpPWpGaD
Roxithromycin—CYP1A2—Metabolism—GSTZ1—urinary bladder cancer	4.81e-05	0.000839	CbGpPWpGaD
Roxithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—urinary bladder cancer	4.8e-05	0.000836	CbGpPWpGaD
Roxithromycin—ABCB1—Metabolism—CYP4B1—urinary bladder cancer	4.71e-05	0.000821	CbGpPWpGaD
Roxithromycin—CYP2B6—Metabolism—TYMP—urinary bladder cancer	4.7e-05	0.000819	CbGpPWpGaD
Roxithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—urinary bladder cancer	4.69e-05	0.000818	CbGpPWpGaD
Roxithromycin—CYP1A2—Metabolism—GSTO2—urinary bladder cancer	4.56e-05	0.000796	CbGpPWpGaD
Roxithromycin—CYP1A2—Metabolism—NAT1—urinary bladder cancer	4.56e-05	0.000796	CbGpPWpGaD
Roxithromycin—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	4.49e-05	0.000783	CbGpPWpGaD
Roxithromycin—ABCB1—Metabolism—SLC19A1—urinary bladder cancer	4.45e-05	0.000775	CbGpPWpGaD
Roxithromycin—ABCB1—Metabolism—PRSS3—urinary bladder cancer	4.33e-05	0.000755	CbGpPWpGaD
Roxithromycin—CYP2B6—Metabolism—NAT2—urinary bladder cancer	4.25e-05	0.00074	CbGpPWpGaD
Roxithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—urinary bladder cancer	4.24e-05	0.000739	CbGpPWpGaD
Roxithromycin—CYP1A2—Metabolism—UGT2B7—urinary bladder cancer	4.17e-05	0.000728	CbGpPWpGaD
Roxithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—urinary bladder cancer	4.1e-05	0.000715	CbGpPWpGaD
Roxithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—urinary bladder cancer	4.09e-05	0.000713	CbGpPWpGaD
Roxithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—urinary bladder cancer	3.9e-05	0.00068	CbGpPWpGaD
Roxithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—urinary bladder cancer	3.79e-05	0.000661	CbGpPWpGaD
Roxithromycin—CYP1A2—Metabolism—CYP4B1—urinary bladder cancer	3.76e-05	0.000655	CbGpPWpGaD
Roxithromycin—CYP3A4—Metabolism—GSTZ1—urinary bladder cancer	3.72e-05	0.000648	CbGpPWpGaD
Roxithromycin—CYP2B6—Metabolism—RRM2—urinary bladder cancer	3.67e-05	0.000639	CbGpPWpGaD
Roxithromycin—CYP1A2—Metabolism—SLC19A1—urinary bladder cancer	3.55e-05	0.000619	CbGpPWpGaD
Roxithromycin—CYP3A4—Metabolism—GSTO2—urinary bladder cancer	3.52e-05	0.000614	CbGpPWpGaD
Roxithromycin—CYP3A4—Metabolism—NAT1—urinary bladder cancer	3.52e-05	0.000614	CbGpPWpGaD
Roxithromycin—ABCB1—Metabolism—TYMP—urinary bladder cancer	3.46e-05	0.000604	CbGpPWpGaD
Roxithromycin—CYP1A2—Metabolism—PRSS3—urinary bladder cancer	3.46e-05	0.000603	CbGpPWpGaD
Roxithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—urinary bladder cancer	3.4e-05	0.000593	CbGpPWpGaD
Roxithromycin—CYP2B6—Metabolism—ENO2—urinary bladder cancer	3.4e-05	0.000592	CbGpPWpGaD
Roxithromycin—CYP2B6—Metabolism—HPGDS—urinary bladder cancer	3.4e-05	0.000592	CbGpPWpGaD
Roxithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—urinary bladder cancer	3.32e-05	0.00058	CbGpPWpGaD
Roxithromycin—CYP2B6—Metabolism—GSTT1—urinary bladder cancer	3.29e-05	0.000574	CbGpPWpGaD
Roxithromycin—CYP3A4—Metabolism—UGT2B7—urinary bladder cancer	3.22e-05	0.000562	CbGpPWpGaD
Roxithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—urinary bladder cancer	3.17e-05	0.000552	CbGpPWpGaD
Roxithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	3.14e-05	0.000547	CbGpPWpGaD
Roxithromycin—ABCB1—Metabolism—NAT2—urinary bladder cancer	3.13e-05	0.000546	CbGpPWpGaD
Roxithromycin—CYP3A4—Metabolism—CYP4B1—urinary bladder cancer	2.9e-05	0.000506	CbGpPWpGaD
Roxithromycin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	2.79e-05	0.000487	CbGpPWpGaD
Roxithromycin—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	2.77e-05	0.000483	CbGpPWpGaD
Roxithromycin—CYP1A2—Metabolism—TYMP—urinary bladder cancer	2.77e-05	0.000482	CbGpPWpGaD
Roxithromycin—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	2.74e-05	0.000478	CbGpPWpGaD
Roxithromycin—CYP2B6—Metabolism—NQO1—urinary bladder cancer	2.74e-05	0.000477	CbGpPWpGaD
Roxithromycin—ABCB1—Metabolism—RRM2—urinary bladder cancer	2.7e-05	0.000471	CbGpPWpGaD
Roxithromycin—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	2.67e-05	0.000465	CbGpPWpGaD
Roxithromycin—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	2.66e-05	0.000463	CbGpPWpGaD
Roxithromycin—ABCB1—Metabolism—HPGDS—urinary bladder cancer	2.5e-05	0.000437	CbGpPWpGaD
Roxithromycin—ABCB1—Metabolism—ENO2—urinary bladder cancer	2.5e-05	0.000437	CbGpPWpGaD
Roxithromycin—CYP1A2—Metabolism—NAT2—urinary bladder cancer	2.5e-05	0.000436	CbGpPWpGaD
Roxithromycin—ABCB1—Metabolism—GSTT1—urinary bladder cancer	2.43e-05	0.000423	CbGpPWpGaD
Roxithromycin—CYP2B6—Metabolism—GSTP1—urinary bladder cancer	2.28e-05	0.000398	CbGpPWpGaD
Roxithromycin—ABCB1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	2.27e-05	0.000396	CbGpPWpGaD
Roxithromycin—CYP1A2—Metabolism—RRM2—urinary bladder cancer	2.16e-05	0.000376	CbGpPWpGaD
Roxithromycin—CYP3A4—Metabolism—TYMP—urinary bladder cancer	2.13e-05	0.000372	CbGpPWpGaD
Roxithromycin—CYP2B6—Metabolism—TYMS—urinary bladder cancer	2.12e-05	0.00037	CbGpPWpGaD
Roxithromycin—CYP2B6—Metabolism—NCOR1—urinary bladder cancer	2.1e-05	0.000366	CbGpPWpGaD
Roxithromycin—CYP2B6—Metabolism—GSTM1—urinary bladder cancer	2.1e-05	0.000366	CbGpPWpGaD
Roxithromycin—ABCB1—Metabolism—NQO1—urinary bladder cancer	2.02e-05	0.000352	CbGpPWpGaD
Roxithromycin—CYP2B6—Metabolism—GPX1—urinary bladder cancer	2.01e-05	0.00035	CbGpPWpGaD
Roxithromycin—CYP1A2—Metabolism—ENO2—urinary bladder cancer	2e-05	0.000348	CbGpPWpGaD
Roxithromycin—CYP1A2—Metabolism—HPGDS—urinary bladder cancer	2e-05	0.000348	CbGpPWpGaD
Roxithromycin—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	1.99e-05	0.000346	CbGpPWpGaD
Roxithromycin—CYP2B6—Metabolism—ERCC2—urinary bladder cancer	1.97e-05	0.000344	CbGpPWpGaD
Roxithromycin—CYP1A2—Metabolism—GSTT1—urinary bladder cancer	1.94e-05	0.000338	CbGpPWpGaD
Roxithromycin—CYP3A4—Metabolism—NAT2—urinary bladder cancer	1.93e-05	0.000336	CbGpPWpGaD
Roxithromycin—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	1.91e-05	0.000333	CbGpPWpGaD
Roxithromycin—CYP2B6—Metabolism—MTHFR—urinary bladder cancer	1.85e-05	0.000323	CbGpPWpGaD
Roxithromycin—ABCB1—Metabolism—GSTP1—urinary bladder cancer	1.68e-05	0.000293	CbGpPWpGaD
Roxithromycin—CYP3A4—Metabolism—RRM2—urinary bladder cancer	1.67e-05	0.00029	CbGpPWpGaD
Roxithromycin—CYP1A2—Metabolism—NQO1—urinary bladder cancer	1.61e-05	0.000281	CbGpPWpGaD
Roxithromycin—ABCB1—Metabolism—TYMS—urinary bladder cancer	1.57e-05	0.000273	CbGpPWpGaD
Roxithromycin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	1.56e-05	0.000273	CbGpPWpGaD
Roxithromycin—ABCB1—Metabolism—NCOR1—urinary bladder cancer	1.55e-05	0.00027	CbGpPWpGaD
Roxithromycin—ABCB1—Metabolism—GSTM1—urinary bladder cancer	1.55e-05	0.00027	CbGpPWpGaD
Roxithromycin—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	1.54e-05	0.000269	CbGpPWpGaD
Roxithromycin—CYP3A4—Metabolism—ENO2—urinary bladder cancer	1.54e-05	0.000269	CbGpPWpGaD
Roxithromycin—CYP2B6—Metabolism—PPARG—urinary bladder cancer	1.5e-05	0.000262	CbGpPWpGaD
Roxithromycin—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	1.5e-05	0.000261	CbGpPWpGaD
Roxithromycin—ABCB1—Metabolism—GPX1—urinary bladder cancer	1.48e-05	0.000258	CbGpPWpGaD
Roxithromycin—ABCB1—Metabolism—ERCC2—urinary bladder cancer	1.45e-05	0.000254	CbGpPWpGaD
Roxithromycin—CYP2B6—Metabolism—CREBBP—urinary bladder cancer	1.44e-05	0.000252	CbGpPWpGaD
Roxithromycin—ABCB1—Metabolism—MTHFR—urinary bladder cancer	1.37e-05	0.000238	CbGpPWpGaD
Roxithromycin—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.36e-05	0.000238	CbGpPWpGaD
Roxithromycin—CYP1A2—Metabolism—GSTP1—urinary bladder cancer	1.34e-05	0.000234	CbGpPWpGaD
Roxithromycin—CYP1A2—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.3e-05	0.000227	CbGpPWpGaD
Roxithromycin—CYP1A2—Metabolism—TYMS—urinary bladder cancer	1.25e-05	0.000218	CbGpPWpGaD
Roxithromycin—CYP3A4—Metabolism—NQO1—urinary bladder cancer	1.24e-05	0.000217	CbGpPWpGaD
Roxithromycin—CYP1A2—Metabolism—GSTM1—urinary bladder cancer	1.24e-05	0.000215	CbGpPWpGaD
Roxithromycin—CYP1A2—Metabolism—NCOR1—urinary bladder cancer	1.24e-05	0.000215	CbGpPWpGaD
Roxithromycin—CYP1A2—Metabolism—GPX1—urinary bladder cancer	1.18e-05	0.000206	CbGpPWpGaD
Roxithromycin—CYP2B6—Metabolism—PTGS2—urinary bladder cancer	1.18e-05	0.000206	CbGpPWpGaD
Roxithromycin—CYP1A2—Metabolism—ERCC2—urinary bladder cancer	1.16e-05	0.000202	CbGpPWpGaD
Roxithromycin—ABCB1—Metabolism—PPARG—urinary bladder cancer	1.11e-05	0.000193	CbGpPWpGaD
Roxithromycin—CYP1A2—Metabolism—MTHFR—urinary bladder cancer	1.09e-05	0.00019	CbGpPWpGaD
Roxithromycin—ABCB1—Metabolism—CREBBP—urinary bladder cancer	1.07e-05	0.000186	CbGpPWpGaD
Roxithromycin—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	1.04e-05	0.000181	CbGpPWpGaD
Roxithromycin—CYP2B6—Metabolism—PTEN—urinary bladder cancer	1.03e-05	0.00018	CbGpPWpGaD
Roxithromycin—CYP2B6—Metabolism—EP300—urinary bladder cancer	9.84e-06	0.000171	CbGpPWpGaD
Roxithromycin—CYP3A4—Metabolism—TYMS—urinary bladder cancer	9.64e-06	0.000168	CbGpPWpGaD
Roxithromycin—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	9.53e-06	0.000166	CbGpPWpGaD
Roxithromycin—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	9.53e-06	0.000166	CbGpPWpGaD
Roxithromycin—CYP3A4—Metabolism—GPX1—urinary bladder cancer	9.13e-06	0.000159	CbGpPWpGaD
Roxithromycin—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	8.96e-06	0.000156	CbGpPWpGaD
Roxithromycin—CYP1A2—Metabolism—PPARG—urinary bladder cancer	8.85e-06	0.000154	CbGpPWpGaD
Roxithromycin—ABCB1—Metabolism—PTGS2—urinary bladder cancer	8.72e-06	0.000152	CbGpPWpGaD
Roxithromycin—CYP1A2—Metabolism—CREBBP—urinary bladder cancer	8.5e-06	0.000148	CbGpPWpGaD
Roxithromycin—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	8.42e-06	0.000147	CbGpPWpGaD
Roxithromycin—ABCB1—Metabolism—PTEN—urinary bladder cancer	7.61e-06	0.000133	CbGpPWpGaD
Roxithromycin—ABCB1—Metabolism—EP300—urinary bladder cancer	7.25e-06	0.000126	CbGpPWpGaD
Roxithromycin—CYP1A2—Metabolism—PTGS2—urinary bladder cancer	6.96e-06	0.000121	CbGpPWpGaD
Roxithromycin—CYP3A4—Metabolism—PPARG—urinary bladder cancer	6.83e-06	0.000119	CbGpPWpGaD
Roxithromycin—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	6.56e-06	0.000114	CbGpPWpGaD
Roxithromycin—CYP1A2—Metabolism—PTEN—urinary bladder cancer	6.07e-06	0.000106	CbGpPWpGaD
Roxithromycin—CYP1A2—Metabolism—EP300—urinary bladder cancer	5.79e-06	0.000101	CbGpPWpGaD
Roxithromycin—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	5.37e-06	9.37e-05	CbGpPWpGaD
Roxithromycin—CYP3A4—Metabolism—PTEN—urinary bladder cancer	4.69e-06	8.17e-05	CbGpPWpGaD
Roxithromycin—CYP3A4—Metabolism—EP300—urinary bladder cancer	4.47e-06	7.79e-05	CbGpPWpGaD
